Shuji Sato

Summary

Publications

  1. ncbi Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody
    Shuji Sato
    Takeda San Francisco, Inc, South San Francisco, California, USA
    PLoS ONE 8:e54509. 2013
  2. ncbi A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF
    Shuji Sato
    Takeda San Francisco, Inc, South San Francisco, California, USA
    PLoS ONE 7:e51964. 2012

Detail Information

Publications2

  1. ncbi Identification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody
    Shuji Sato
    Takeda San Francisco, Inc, South San Francisco, California, USA
    PLoS ONE 8:e54509. 2013
    ..In this study, we utilized the anti-HB-EGF monoclonal antibodies Y-142 and Y-073, which have differential specificities toward proHB-EGF, in order to elucidate proHB-EGF functions in cancer cells...
  2. ncbi A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGF
    Shuji Sato
    Takeda San Francisco, Inc, South San Francisco, California, USA
    PLoS ONE 7:e51964. 2012
    ..Y-142 may have a potential to be developed into a therapeutic agent for the treatment of HB-EGF-dependent cancers...